Citation Impact
1 by Nobel laureates 59 standout
Citing Papers
Senescence drives immunotherapy resistance by inducing an immunosuppressive tumor microenvironment
2024 Standout
Thyroid Cancer
2024 Standout
Works of Min Ren being referenced
A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer
2015
A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine‐refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment
2015
Author Peers
| Author | PRM | Hepatology | Molecular Biology | Oncology | EDM | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|---|
| Min Ren | 319 | 248 | 320 | 400 | 382 | 75 | 1.6k | |
| Tienah H. H. Elagib | 7 | 1 | 12 | 367 | ||||
| S.A. Gee | 10 | 239 | ||||||
| Angela McRae | 1 | 4 | 512 | |||||
| Lili Aslostovar | 6 | 2 | 229 | 71 | 1 | 8 | 392 | |
| Lesly‐Anne Samedy | 63 | 37 | 5 | 2 | 6 | 243 |
All Works
Login with ORCID to disown or claim papers
Loading papers...